Possible treatment for incurable lung disease discovered

Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to: http://www.uab.edu/news/latest/item/3282-uab-researchers-discover-possible-treatment-for-incurable-lung-disease

 

Employee of the Month

Becky Wallace has been selected as the Department of Medicine Employee of BeckyWallacethe Month for March 2015!     Becky is an Administrative Associate in the Division of Pulmonary, Allergy and Critical Care Medicine.  She was notified by Jason Daniel, DOM Executive Administrator and Megann Cain, Senior Director of Development and Strategic Planning/DOM Chief of Staff. Read more...

Research Spotlight

Kirk Habegger, PhDKirk Habegger, PhD

Dr. Kirk M. Habegger is Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. He obtained his Ph.D. in Biochemistry and Molecular Biology from Indiana University School of Medicine in 2006. He conducted his postdoctoral training under the mentorship of Drs. Matthias Tschoep and Randy Seeley at the Metabolic Diseases Institute of the University of Cincinnati from 2009 to 2013. He was promoted to the faculty at UC in the Department of Medicine, before leaving to start his group at UAB.

Read more...